Form D — Kayak Therapeutics, Inc.
0002088831-25-000001 · filed Sep 29, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $10,000,000
- Reported amount sold
- $6,630,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Kayak Therapeutics, Inc.
- CIK
- 2088831
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 3317 BOWMAN AVENUE
AUSTIN, Texas 78703 - Phone
- 917.892.9996
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Tyler Brous · DirectorAustin, Texas Find on LinkedIn ↗
-
Conor Richardson · Executive OfficerAustin, Texas Find on LinkedIn ↗
-
Hornblower Josiah · Executive OfficerAustin, Texas Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗